Alembic Pharmaceuticals incorporated a wholly owned subsidiary, Alembic Pharmaceuticals GmbH, in Germany.
The subsidiary has an initial share capital of EUR 25,000 and has not yet commenced business operations.
The purpose is to explore new business opportunities for promoting, selling, and distributing the company's pharmaceutical products in that geography.
This intimation is made under Regulation 30 of the SEBI LODR Regulations, 2015.